naphazoline has been researched along with Epilepsy in 2 studies
Naphazoline: An adrenergic vasoconstrictor agent used as a decongestant.
Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nafimidone is a new antiepileptic drug which may be effective in partial onset seizures." | 5.27 | Pharmacokinetics of nafimidone in patients with chronic intractable epilepsy. ( Gunawan, S; Treiman, DM, 1987) |
| "Nafimidone is a new antiepileptic drug which may be effective in partial onset seizures." | 1.27 | Pharmacokinetics of nafimidone in patients with chronic intractable epilepsy. ( Gunawan, S; Treiman, DM, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sari, S | 1 |
| Barut, B | 1 |
| Marcinkowska, M | 1 |
| Sabuncuoğlu, S | 1 |
| Avci, A | 1 |
| Koçak Aslan, E | 1 |
| Özel, A | 1 |
| Siwek, A | 1 |
| Treiman, DM | 1 |
| Gunawan, S | 1 |
2 other studies available for naphazoline and Epilepsy
| Article | Year |
|---|---|
Potential of nafimidone derivatives against co-morbidities of epilepsy: In vitro, in vivo, and in silico investigations.
Topics: Acetylcholinesterase; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Epilepsy; Mice; Mol | 2022 |
Pharmacokinetics of nafimidone in patients with chronic intractable epilepsy.
Topics: Adult; Anticonvulsants; Chronic Disease; Epilepsy; Female; Half-Life; Humans; Imidazoles; Kinetics; | 1987 |